The generics drug market is projected to experience a 6.51% CAGR during between 2018 and 2028, according to a report from Research & Markets. The generics sector was valued at $416.06B last year, according to the report.
The rise in chronic diseases–combined with a demand for lower-cost medications– has driven demand for generic drugs.